Skip to results
Modify your search
NARROW
1-20 of 34
Authors: Javier P Gisbert
Journal Article
Characterization of the Regulatory Landscape in Crohn’s Disease Reveals microRNA-Associated Alterations that Shape Anti-TNF Response Open Access
Inflammatory Bowel Diseases, izaf029, https://doi.org/10.1093/ibd/izaf029
Published: 11 March 2025
Journal Article
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study Open Access
Inflammatory Bowel Diseases, Volume 31, Issue 5, May 2025, Pages 1281–1294, https://doi.org/10.1093/ibd/izae162
Published: 10 August 2024
Journal Article
EDITOR'S CHOICE
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients Free
Inflammatory Bowel Diseases, Volume 30, Issue 2, February 2024, Pages 167–182, https://doi.org/10.1093/ibd/izad154
Published: 03 August 2023
Journal Article
Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review Open Access
Inflammatory Bowel Diseases, Volume 30, Issue 2, February 2024, Pages 292–302, https://doi.org/10.1093/ibd/izac275
Published: 28 January 2023
Journal Article
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study Free
Inflammatory Bowel Diseases, Volume 28, Issue 11, November 2022, Pages 1725–1736, https://doi.org/10.1093/ibd/izab357
Published: 15 February 2022
Journal Article
EDITOR'S CHOICE
Tissue Proteomic Approaches to Understand the Pathogenesis of Inflammatory Bowel Disease Free
Inflammatory Bowel Diseases, Volume 27, Issue 8, August 2021, Pages 1184–1200, https://doi.org/10.1093/ibd/izaa352
Published: 02 February 2021
Journal Article
Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel Disease Free
Inflammatory Bowel Diseases, Volume 27, Issue 2, February 2021, Pages 268–274, https://doi.org/10.1093/ibd/izaa151
Published: 17 June 2020
Journal Article
Response to the Letter to the Editor: “Response to Infliximab After Loss of Response to Adalimumab in Crohn’s Disease” Get access
Inflammatory Bowel Diseases, Volume 26, Issue 2, February 2020, Page e6, https://doi.org/10.1093/ibd/izz287
Published: 21 November 2019
Journal Article
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry Get access
Inflammatory Bowel Diseases, Volume 26, Issue 4, April 2020, Pages 606–616, https://doi.org/10.1093/ibd/izz192
Published: 29 August 2019
Journal Article
Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry Get access
Inflammatory Bowel Diseases, Volume 25, Issue 11, November 2019, Pages 1862–1870, https://doi.org/10.1093/ibd/izz084
Published: 22 April 2019
Journal Article
EDITOR'S CHOICE
The Innate Immune System in the Gastrointestinal Tract: Role of Intraepithelial Lymphocytes and Lamina Propria Innate Lymphoid Cells in Intestinal Inflammation Get access
Inflammatory Bowel Diseases, Volume 24, Issue 8, August 2018, Pages 1649–1659, https://doi.org/10.1093/ibd/izy177
Published: 18 May 2018
Journal Article
Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis Get access
Inflammatory Bowel Diseases, Volume 23, Issue 8, 1 August 2017, Pages 1394–1402, https://doi.org/10.1097/MIB.0000000000001144
Published: 30 June 2017
Journal Article
Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease Get access
Inflammatory Bowel Diseases, Volume 23, Issue 7, 1 July 2017, Pages 1144–1153, https://doi.org/10.1097/MIB.0000000000001081
Published: 16 May 2017
Journal Article
Ustekinumab for the Treatment of Refractory Crohn's Disease: The Spanish Experience in a Large Multicentre Open-label Cohort Get access
Inflammatory Bowel Diseases, Volume 22, Issue 7, 1 July 2016, Pages 1662–1669, https://doi.org/10.1097/MIB.0000000000000842
Published: 10 June 2016
Journal Article
Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease: A 5-Year Prospective Study Get access
Inflammatory Bowel Diseases, Volume 22, Issue 8, 1 August 2016, Pages 1929–1936, https://doi.org/10.1097/MIB.0000000000000815
Published: 02 May 2016
Journal Article
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study Get access
Inflammatory Bowel Diseases, Volume 22, Issue 4, 1 April 2016, Pages 894–901, https://doi.org/10.1097/MIB.0000000000000757
Published: 02 March 2016
Journal Article
Physician Perspectives on Unresolved Issues in the Management of Ulcerative Colitis: The UC Horizons Project Get access
Inflammatory Bowel Diseases, Volume 22, Issue 3, 1 March 2016, Pages 583–598, https://doi.org/10.1097/MIB.0000000000000617
Published: 02 November 2015
Journal Article
The Effects of Infliximab or Adalimumab on Vascular Endothelial Growth Factor and Angiopoietin 1 Angiogenic Factor Levels in Inflammatory Bowel Disease: Serial Observations in 37 Patients Get access
Inflammatory Bowel Diseases, Volume 20, Issue 4, 1 April 2014, Pages 695–702, https://doi.org/10.1097/MIB.0000000000000004
Published: 20 February 2014
Journal Article
Safety of Thiopurine Therapy in Inflammatory Bowel Disease: Long-term Follow-up Study of 3931 Patients
Get access
Inflammatory Bowel Diseases, Volume 19, Issue 7, 1 June 2013, Pages 1404–1410, https://doi.org/10.1097/MIB.0b013e318281f28f
Published: 09 May 2013
Journal Article
Impact of Current Smoking on the Clinical Course of Microscopic Colitis Get access
Inflammatory Bowel Diseases, Volume 19, Issue 7, 1 June 2013, Pages 1470–1476, https://doi.org/10.1097/MIB.0b013e318281f3cc
Published: 02 April 2013
